1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Opioid Induced Constipation Drugs Market
2.2. Global Opioid Induced Constipation Drugs Market, By Drug Type, 2023 (US$ Million)
2.3. Global Opioid Induced Constipation Drugs Market, By Prescription Type, 2023 (US$ Million)
2.4. Global Opioid Induced Constipation Drugs Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Opioid Induced Constipation Drugs Market: Competitive Analysis
3.1. Market Positioning of Key Opioid Induced Constipation Drugs Market Vendors
3.2. Strategies Adopted by Opioid Induced Constipation Drugs Market Vendors
3.3. Key Industry Strategies
4. Opioid Induced Constipation Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Opioid Induced Constipation Drugs Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Methylnaltrexone Bromide
5.3.2. Lubiprostone
5.3.3. Naloxegol
5.3.4. Naldemedine
5.3.5. Docusate Sodium
5.3.6. Others

6. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Prescribed
6.3.1.1. Branded
6.3.1.2. Generic
6.3.2. Over the Counter (OTC)


7. North America Opioid Induced Constipation Drugs Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
7.3. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
7.4.Opioid Induced Constipation Drugs Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
7.4.1.1.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
7.4.1.2.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
7.4.1.3.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)

8. UK and European Union Opioid Induced Constipation Drugs Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.3. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.Opioid Induced Constipation Drugs Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.1.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.2.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.3.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.4.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.5.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
8.4.1.6.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)

9. Asia Pacific Opioid Induced Constipation Drugs Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.3. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.Opioid Induced Constipation Drugs Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.1.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.2.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.3.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.4.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.5.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.4.1.6.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)

10. Latin America Opioid Induced Constipation Drugs Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.3. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
10.4.Opioid Induced Constipation Drugs Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.4.1.1.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.4.1.2.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.4.1.3.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)

11. Middle East and Africa Opioid Induced Constipation Drugs Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.3. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
11.4.Opioid Induced Constipation Drugs Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.4.1.1.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.4.1.2.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Opioid Induced Constipation Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.4.1.3.2. Opioid Induced Constipation Drugs Market: By Prescription Type, 2022-2032, USD (Million)

12. Company Profile
12.1. AstraZeneca plc
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Cubist Pharmaceuticals (Adolor Corporation)
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Daiichi Sankyo Co., Ltd.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Ironwood Pharmaceuticals, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Pfizer, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Progenics Pharmaceuticals, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Salix Pharmaceuticals Ltd.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Shionogo & Co., Ltd.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Sucampo Pharmaceuticals, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Synergy Pharmaceuticals, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives